CHAPTER 8 Superficial Cold and Heat

Week 2 + CHAPTER 8: Superficial Cold and Heat

Prepared by: Sherman Mercado


CHAPTER 8: Superficial Cold and Heat

Prepared by: Michelle H. Cameron

Introduction to Cryotherapy and Thermotherapy

  • Classification:

    • Deep vs. Superficial

      • Basis of application and depth of temperature change.

  • Superficial Cooling/Heating Agents:

    • Conduction: Cold packs, hot packs, paraffin wax.

    • Convection: Whirlpool therapy, Fluidotherapy.

    • Radiation: Infrared lamps.

  • Note: Deep-heating agents (e.g., ultrasound, diathermy) are not covered.

    • Focus on superficial heating agents in this chapter.


Cryotherapy

Definition and Clinical Applications

  • Cryotherapy: Use of cold for therapeutic purposes.

    • Applications include rehabilitation and tissue destruction (benign/malignant).

  • Whole-body therapeutic hypothermia:

    • Used post-cardiac arrest, severe stroke, or neurological trauma.

    • Target Body Temperature: 32°C to 35°C (89.6°F to 95°F).

    • Benefits include decreased tissue temperature and muscle soreness prevention.


Effects of Cold

Hemodynamic Effects

Initial Decrease in Blood Flow
  • Mechanism: Initial cold application causes:

  • Vasoconstriction of skin vessels.

  • Reduced blood flow (approx. 40% decrease) in applied area.

  • Lasting effects during and after cooling session.

Mechanisms of Vasoconstriction:
  • Activation of cold receptors; increase in blood viscosity; reduced release of vasodilators (e.g., histamine, prostaglandins).

  • Reflex activation of sympathetic neurons leading to regional vasoconstriction.

Temperature Regulation

Body Response to Cold
  • Body decreases blood flow in response to cold to protect core temperature and prevent excessive cooling of tissues.

  • Increased localized cooling leads to reduced circulation elsewhere in the body.


Later Increase in Blood Flow

  • Cold-Induced Vasodilation (CIVD):

    • Occurs when cooling extends over periods or tissue temperature falls below 10°C (50°F).

    • First reported by Sir Thomas Lewis (1930); cyclic temperature changes occur after prolonged cold exposure.

    • Phenomenon mediators include:

      • Axon reflex due to pain from prolonged cold.

      • Reflexive vasodilation response in distal extremities, primarily fingers and toes.


Neuromuscular Effects of Cold

Decreased Nerve Conduction Velocity

  • Nerve conduction velocity decreases due to reduced temperature; effects vary based on time and duration of cooling.

  • Recovery time after cooling is relatively quick (15-30 minutes).

Pain Reduction Mechanisms

  • Cold application activates gate control mechanisms, reduces muscle spasm, and overall decreases post-injury edema.

Muscle Strength Changes

  • Isometric muscle strength may increase:

    • After brief cooling but decrease with prolonged cooling (over 15 minutes).

    • Strength assessment recommended before cryotherapy.


Decreased Spasticity

  • Cryotherapy can briefly reduce spasticity and alter stretch reflexes.

  • Longer applications (10-30 min) can lead to sustained effects on muscle tone, useful during therapeutic activities.

Facilitation of Muscle Contraction

  • Brief cryotherapy can trigger alpha motor neuron activity assisting in muscle contraction in cases of flaccidity.


Metabolic Effects of Cold

Decreased Metabolic Rate

  • Cryotherapy slows metabolic reactions, beneficial for inflammation control but should be used cautiously if healing is delayed.

Clinical Indications

Inflammation Control
  • Reduces inflammation symptoms: heat, redness, edema, pain, and function loss within tissue healing phases.

  • Counteracts microvascular damage from inflammation.

Edema Control
  • Effective immediately post-acute trauma combined with compression and elevation.

Pain Control
  • Modifies sensation through direct cold effects and by addressing underlying causes (e.g., inflammation).


Clinical Indications for Cryotherapy

Spasticity Modification

  • Brief cold applications reduce deep tendon reflexes, while longer applications can eliminate clonus.

Multiple Sclerosis (MS)

  • Patients may present heat sensitivity; controlled cooling alleviates symptoms.


Contraindications for Cryotherapy

  • Cold hypersensitivity, intolerance, cryoglobulinemia, Raynaud’s phenomenon, and over areas with circulatory compromise or regenerating nerves.

Specific Conditions

  • Cold hypersensitivity: Itchy, red patches; cold intolerance may result in pain and numbness.

  • Raynaud’s: Characterized by vasospasm and skin color changes.


Precautions for Cryotherapy

  • Apply caution in patients with impaired sensation or at extremes of age; monitoring for adverse effects is critical.


Application Techniques

General Cryotherapy

  • Tools include cold packs, ice cups, contrast baths. Sequence of sensations: cold > burning > aching > numbness.

Specific Techniques

  • Ice massage: 5-10 minutes; useful in motor pattern facilitation.

  • Controlled cold compression units: Effective in cooling and assisting recovery.

Vapocoolant Sprays

  • Used before stretching for myofascial pain syndromes.


Thermotherapy: Heat Application

Effects of Heat

Hemodynamic Effects
  • Vasodilation increases blood flow, impacts distal cutaneous vessels, and stimulates thermoreceptors.

Neuromuscular Effects

Changes in Nerve Conduction Velocity
  • Increases speed of nerve conduction; may reduce pain perception.


Clinical Indications for Superficial Heat

  • Relief for joint stiffness, increased range of motion, pain control via sensory pathways, and assistance in healing processes.

Precautions and Contraindications

  • Avoid in recent hemorrhage, thrombosis, impaired sensation, etc.


Adverse Effects of Thermotherapy

Burns and Tissue Damage
  • Protein denaturation at high temperatures can lead to cell death; ensure proper application duration and monitoring.

Documentation of Cryotherapy and Thermotherapy

  • Essential to record treated areas, type of agent, duration, and patient response.

Example Documentation

  • Detailed records of interventions, patient symptoms, and outcomes are crucial for ongoing treatment planning.